PMID- 33889649 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220422 IS - 2325-9671 (Print) IS - 2325-9671 (Electronic) IS - 2325-9671 (Linking) VI - 9 IP - 4 DP - 2021 Apr TI - Defining Minimal Clinically Important Difference After Open Hip Abductor Repair. PG - 23259671211007740 LID - 10.1177/23259671211007740 [doi] LID - 23259671211007740 AB - BACKGROUND: Open repair for gluteus medius and minimus tears is a common surgical treatment for patients with lateral hip pain associated with abductor tears; however, clinically meaningful outcomes have not been described after open surgical treatment. PURPOSE: To define the minimal clinically important difference (MCID) in patient-reported outcome measures (PROMs) in patients undergoing open gluteus medius or minimus repair, and to identify preoperative patient characteristics predictive of achieving MCID postoperatively. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A retrospective review of prospectively collected data from a consecutive series of patients undergoing open abductor repair between July 2010 and April 2019 was conducted. Perioperative patient data collected included patient characteristics and preoperative and postoperative modified Harris Hip Score (mHHS) and International Hip Outcome Tool (iHOT-33) score. Paired t tests were utilized to compare preoperative and postoperative PROMs and MCID was calculated for both PROMs. Multivariate logistical regression analysis was used to assess the association between preoperative variables and the likelihood for achieving MCID. RESULTS: A total of 47 patients were included in the study. The majority of patients were female (78.7%), with an average age of 63 +/- 10.7 years. The average follow-up for both the mHHS and the iHOT-33 surveys was 37.8 +/- 27.9 months (range, 10-102 months). Patients demonstrated statistically significant improvements on the mHHS and iHOT-33 postoperatively (P < .001 for both). The MCIDs of mHHS and iHOT-33 were calculated to be 9.9 and 14.3, respectively. Overall, 82.9% of patients achieved MCID for mHHS and 84.1% of patients achieved MCID for iHOT-33 postoperatively. Multivariate logistical analysis demonstrated younger patients were less likely to achieve MCID for both outcome measures. Four patients (8.5%) suffered postoperative complications after open repair. CONCLUSION: This study defined MCID for mHHS and iHOT-33 for patients undergoing open repair of hip abductor tears, with a large percentage of patients (>80%) achieving meaningful outcomes for both outcome measures. There was a low complication rate. Younger patients were less likely to achieve MCID compared with older patients. CI - (c) The Author(s) 2021. FAU - Uppstrom, Tyler J AU - Uppstrom TJ AD - Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA. RINGGOLD: 25062 FAU - Sullivan, Spencer W AU - Sullivan SW AD - Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA. RINGGOLD: 25062 FAU - Burger, Joost A AU - Burger JA AD - Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA. RINGGOLD: 25062 FAU - Ranawat, Anil S AU - Ranawat AS AD - Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA. RINGGOLD: 25062 FAU - Kelly, Bryan T AU - Kelly BT AD - Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA. RINGGOLD: 25062 FAU - Nwachukwu, Benedict U AU - Nwachukwu BU AD - Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA. RINGGOLD: 25062 LA - eng PT - Journal Article DEP - 20210407 PL - United States TA - Orthop J Sports Med JT - Orthopaedic journal of sports medicine JID - 101620522 PMC - PMC8033401 OTO - NOTNLM OT - MCID OT - abductor repair OT - gluteus medius OT - hip OT - outcomes OT - trochanteric pain syndrome COIS- One or more of the authors has declared the following potential conflict of interest or source of funding: A.S.R. has received consulting fees from Anika, Arthrex, Bodycad, Enhach, Heron, Smith & Nephew, and Stryker and nonconsulting fees from Arthrex and Smith & Nephew; and has ownership interests in Conformis and Enhatch. B.T.K. has received consulting fees from Arthrex, Organicell, and Smith & Nephew; faculty/speaker fees from Synthes GmbH; nonconsulting fees and royalties from Arthrex; and stock/stock options from Organicell. B.U.N. has received research support from Arthrex; education payments from Arthrex and Smith & Nephew; and hospitality payments from Stryker, Wright Medical, and Zimmer Biomet; and has an ownership interest in Remote Health. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. EDAT- 2021/04/24 06:00 MHDA- 2021/04/24 06:01 PMCR- 2021/04/07 CRDT- 2021/04/23 06:29 PHST- 2020/08/05 00:00 [received] PHST- 2020/08/25 00:00 [accepted] PHST- 2021/04/23 06:29 [entrez] PHST- 2021/04/24 06:00 [pubmed] PHST- 2021/04/24 06:01 [medline] PHST- 2021/04/07 00:00 [pmc-release] AID - 10.1177_23259671211007740 [pii] AID - 10.1177/23259671211007740 [doi] PST - epublish SO - Orthop J Sports Med. 2021 Apr 7;9(4):23259671211007740. doi: 10.1177/23259671211007740. eCollection 2021 Apr.